Adagio Medical Holdings Free Cash Flow 2020-2024 | ADGM
Adagio Medical Holdings free cash flow from 2020 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Adagio Medical Holdings Annual Free Cash Flow | |
|---|---|
| 2024 | -31.11 |
| 2023 | -25.99 |
| 2022 | -0.49 |
| 2021 | -1.07 |
| 2020 | 0.00 |
| 2019 | 0.00 |
| Adagio Medical Holdings Quarterly Free Cash Flow | |
|---|---|
| 2024-12-31 | -31.11 |
| 2024-09-30 | -6.94 |
| 2024-06-30 | |
| 2024-03-31 | -0.51 |
| 2023-12-31 | -25.99 |
| 2023-09-30 | -35.24 |
| 2023-06-30 | -0.65 |
| 2023-03-31 | -0.21 |
| 2022-12-31 | -0.49 |
| 2022-09-30 | -0.43 |
| 2022-06-30 | -0.41 |
| 2022-03-31 | -0.08 |
| 2021-12-31 | -1.07 |
| 2021-09-30 | -0.95 |
| 2021-06-30 | -0.81 |
| 2021-03-31 | -0.76 |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.019B | $0.001B |
| Adagio Medical is a developmental stage medical device company which focuses on developing cryoablation technologies which create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter and ventricular tachycardia. Adagio Medical, formerly known as ARYA Sciences Acquisition Corp IV, is based in LAGUNA HILLS, Calif. | |||